Step 1 topics → Reproductive → Gonadal Differentiation (SRY, MIS, Testosterone)

Gonadal Differentiation (SRY, MIS, Testosterone)

USMLE Step 1 trap: Confuses SRY as a dual activator/suppressor rather than a unidirectional testis-inducing switch. SRY only drives testis determination; suppression of the female pathway is accomplished by downstream factors (e.g., SOX9 suppressing WNT4/FOXL2), not SRY directly.

Gonadal differentiation is one of the most reliably tested embryology topics on USMLE Step 1. The core concept is that every embryo starts with a bipotential gonad, and the presence or absence of the SRY gene on the Y chromosome determines which path it takes. SRY encodes testis-determining factor (TDF), which drives Sertoli cell differentiation — and from there, a coordinated hormonal cascade (MIS from Sertoli cells, testosterone from Leydig cells, and DHT from peripheral 5α-reductase activity) masculinizes the internal and external genitalia. Without SRY, the gonad defaults to an ovary, and without MIS or androgens, the phenotype defaults to female.

The exam tests this in several ways: direct recall of which cell produces which hormone, mechanistic questions about what happens when a specific hormone or enzyme is absent (think 5α-reductase deficiency or androgen insensitivity), and passage-based vignettes describing a patient's phenotype that you must trace back to a specific molecular or hormonal failure. The 'three hormones' framework — MIS, testosterone, DHT, their sources, and their targets — is the engine behind nearly every clinical scenario involving ambiguous genitalia or disorders of sexual differentiation.

What makes this tricky is that students often overcomplicate SRY's role or misremember which testicular cell makes which hormone. SRY is a unidirectional switch — it turns on testis determination, period. And a very common exam trap is attributing MIS to Leydig cells instead of Sertoli cells. Similarly, many students assume female development is an active, hormone-driven process — it isn't. Understanding that female is the hormonal default, requiring no ovarian input, is essential for answering USMLE Step 1 questions about gonadal dysgenesis, Turner syndrome, and androgen insensitivity correctly.

From real student decks
84%have cards covering this topic
81%have mature cards

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: SRY actively suppresses female development in addition to inducing testis formation.
Right: SRY only drives testis determination; suppression of the female pathway is accomplished by downstream factors (e.g., SOX9 suppressing WNT4/FOXL2), not SRY directly.
SRY is a one-way switch — it triggers testis determination by activating SOX9 and related factors, but it does not itself suppress female development. The suppression of WNT4/FOXL2 (the pro-ovarian pathways) is done by downstream factors like SOX9, not by SRY directly. Think of SRY as pulling the first domino; everything downstream is a separate cascade. This distinction matters because mutations in downstream regulators can cause sex reversal even with an intact SRY.
Common mistake
Wrong: MIS (anti-Müllerian hormone) is produced by Leydig cells.
Right: MIS is produced by Sertoli cells, while testosterone is produced by Leydig cells.
Sertoli cells make MIS (anti-Müllerian hormone); Leydig cells make testosterone. These are different testicular cell types with different functions and different embryological timings. A clean mnemonic: Sertoli = support cells that Suppress Müllerian structures. Leydig cells are the steroidogenic cells that produce androgens. On USMLE Step 1, a question about persistent Müllerian duct syndrome (male with uterus and fallopian tubes) specifically implicates MIS failure — i.e., Sertoli cell dysfunction, not Leydig.
Common mistake
Wrong: Female development requires active hormonal signaling from the ovary.
Right: Female development is the default pathway and proceeds in the absence of SRY, MIS, and androgens — no ovarian hormones are required for basic female phenotype.
Female differentiation does not require active hormonal signaling from the ovary — it happens by default when MIS and androgens are absent. This is proven by experiments in castrated embryos: remove the gonads, and the result is always a female phenotype regardless of chromosomal sex. Ovarian hormones (estrogen, etc.) matter later for pubertal development, but the basic female structural differentiation in the embryo is essentially a passive process.
Common mistake
Wrong: DHT is secreted directly by the fetal testis.
Right: DHT is not secreted by the testis; it is converted locally from testosterone by 5α-reductase in target tissues such as the urogenital sinus and external genitalia.
The testis secretes testosterone, not DHT. DHT is made locally at target tissues — specifically the urogenital sinus, genital tubercle, and labioscrotal folds — where 5α-reductase converts testosterone into the more potent DHT. This is why 5α-reductase deficiency causes normal internal male structures (testosterone-dependent Wolffian development is intact) but ambiguous or female-appearing external genitalia (DHT-dependent masculinization fails). If the testis secreted DHT directly, this phenotype wouldn't make sense.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the role of SRY: it encodes testis-determining factor (TDF) and drives the bipotential gonad toward testis formation — this is the first and essential step in male differentiation.
  2. Know all three fetal hormones, their cellular sources, and what each one does: MIS (from Sertoli cells) causes regression of Müllerian ducts; testosterone (from Leydig cells) virilizes Wolffian ducts; DHT (converted from testosterone by 5α-reductase in target tissues) masculinizes the external genitalia and urogenital sinus.
  3. Understand why female is the default phenotype: in the absence of SRY, MIS, and androgens, the Müllerian ducts persist, the Wolffian ducts regress, and female external genitalia develop — no ovarian hormones are required for this baseline female outcome.

Can you avoid these mistakes?

A 46,XY individual is born with female external genitalia, normal testes (undescended), and no uterus or fallopian tubes. Which hormone is most likely functioning normally, and which is most likely deficient or non-functional?
You remove the gonads from a chromosomally male (46,XY) embryo before any hormonal secretion begins. What phenotype will develop, and why?
A patient has 46,XY chromosomes, a uterus, fallopian tubes, and virilized external genitalia. Which specific cell type and which specific hormone are most likely defective?
What is the difference between the tissue source and the site of action for testosterone versus DHT in male fetal development? Why does this distinction matter for understanding 5α-reductase deficiency?

Related topics

Müllerian vs Wolffian Duct Derivatives 5α-Reductase Deficiency Complete Androgen Insensitivity Syndrome (CAIS) Müllerian Anomalies (Bicornuate, Septate, MRKH)

See how your Anki deck covers this topic.

Upload your deck for a free audit →